Isoproterenol Hydrochloride Injection, Solution
Product Images NDC 25021-324

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Isoproterenol Hydrochloride (NDC 25021-324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Iso0e 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Iso0e 0000 02)

Package Label – Principal Display Panel – Vial Label (Iso0e 0000 02)
This text contains information about an intravenous use only medication called SAGENT. The medication is a Hydrochloride Injection manufactured in India. It comes in a 1 mL single-dose vial and needs to be protected from light. The lot/exp number is indicated as "See Below".*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Iso0e 0000 03)

Package Label – Principal Display Panel – Vial Label (Iso0e 0000 03)
This is a description of Isoproterenol Hydrochloride Injection, USP with a concentration of 1 mg per 5 mL (0.2 mg per mL). It is a sterile injection for intravenous use only, packaged in a 5 mL single-dose vial. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) and should be protected from light. The manufacturer is SAGENT Pharmaceuticals based in Schaumburg, IL, USA, with the product made in India. The indicated expiration or manufacture date is coded as TS/DRUGS/2/2015.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.